SCHEMBL26924969

SCHEMBL26924969

Cn1nc(-c2ccc(OCc3ccccc3)nc2OCc2ccccc2)c2ccc(CN3CCC4(CC3)CCN(C(=O)OC(C)(C)C)CC4)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 6/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ NSD2 O96028 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ TLR9 Q9NR96 3/20 0.37
▸ TLR7 Q9NYK1 2/20 0.37
▸ RORC P51449 1/20 0.36
▸ CHRM2 P08172 2/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ TDO2 P48775 1/20 0.36
▸ IDO2 Q6ZQW0 1/20 0.36
▸ TNKS O95271 1/20 0.36
▸ PARP1 P09874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30732198 1.00 CYP2D6 (0.39) CYP2D6CYP3A4USP2ALDH1A1MAPK1
SCHEMBL30731789 0.89 GPR119 (0.41) CYP3A4USP2MAPK1OPRD1OPRK1
SCHEMBL26924752 0.89 GPR119 (0.41) CYP3A4USP2MAPK1OPRD1OPRK1
SCHEMBL26925663 0.88 NSD2 (0.39) ALDH1A1NSD2TLR9TLR7IDO1
SCHEMBL34461203 0.87 PRMT5 (0.39) OPRD1OPRK1TLR9TLR7GPR119
SCHEMBL26925586 0.86 OPRD1 (0.39) OPRD1OPRK1TLR9TLR7GPR119
SCHEMBL30731996 0.86 OPRD1 (0.39) OPRD1OPRK1TLR9TLR7GPR119
SCHEMBL26925336 0.86 GPR119 (0.38) TLR9TLR7GPR119YAP1
SCHEMBL30706160 0.86 GPR119 (0.38) TLR9TLR7GPR119YAP1
SCHEMBL31554749 0.85 YAP1 (0.44) TLR9TLR7GPR119YAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276981-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. 2025-09-04 — — US disclosed
US-20240287091-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. 2024-08-29 — — US disclosed
WO-2023240038-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. (US) 2023-12-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287091-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS BCL6, BCL6B, BCOR CYP2D6 363/4885CYP3A4 701/4885USP2 410/4885
US-20250276981-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS BCL6, BCL6B, BCOR CYP2D6 363/4885CYP3A4 701/4885USP2 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback